文献速递免疫规划

小鼠皮内接种肺炎球菌结合疫苗诱导的抗体应答低于肌内接种

Intradermal administration of the pneumococcal conjugate vaccine in mice results in lower antibody responses as compared to intramuscular administration.
PubMed 文献 · Vaccine · 2022-11-26

研究比较了小鼠皮内与肌内接种13价肺炎球菌结合疫苗(PCV13)后的抗体应答及对鼻内定植的保护。结果显示,肌内接种组血清和黏膜抗体水平均高于皮内接种组,两种途径均未观察到对肺炎链球菌鼻内定植的保护。结论认为皮内接种诱导血清型特异性抗体劣于肌内接种。

要点

  • 肌内接种组血清和黏膜抗体水平均高于皮内接种组。
  • 两种接种途径均未观察到对肺炎链球菌鼻内定植的保护。
  • 皮内接种诱导血清型特异性抗体劣于肌内接种。

核心结论

  • 皮内接种诱导血清型特异性抗体劣于肌内接种。

研究设计与样本

  • 小鼠分别经皮内或肌内接种PCV13,鼻内定植血清型4临床株后3天或7天测定鼻组织CFU计数,并用荧光珠多重免疫法测定血和黏膜样本中针对全部13种多糖的抗体浓度。

主要发现

  • 肌内接种组血清和黏膜样本抗体水平均高于皮内接种组。
  • 两种接种途径均未观察到对肺炎链球菌鼻内定植的保护。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Several studies have shown that intradermal vaccination leads to improved immune responses. In addition, lowering vaccine doses will reduce costs and therefore potentially increase coverage. To determine whether intradermal delivery enhances the antibody responses against the 13-valent pneumococcal conjugate vaccine (PCV13), we compared intradermally and intramuscularly vaccinated mice. METHODS: Mice were immunized with PCV13, either intradermally or intramuscularly and CFU-counts in the nasal tissue were determined three or seven days after intranasal colonization with a serotype 4 clinical strain. Antibody concentrations against all thirteen polysaccharides were measured in blood and mucosal samples using a fluorescent-bead-based multiplex immunoassay. RESULTS: Antibody levels in both serum and mucosal samples were higher in the intramuscularly vaccinated group as compared to the intradermally vaccinated group. No protection against S. pneumoniae intranasal colonization was observed for either vaccination route. CONCLUSIONS: Intradermal vaccination was inferior to intramuscular immunization in inducing serotype-specific antibodies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Uijen RF, van Beek LF, van Opzeeland F, et al. Intradermal administration of the pneumococcal conjugate vaccine in mice results in lower antibody responses as compared to intramuscular administration. Vaccine. 2022. PMID: 36446656. doi:10.1016/j.vaccine.2022.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。